Article
HSP70L1-mediated intracellular priming of dendritic cell vaccination induces more potent CTL response against cancer.
Cellular & molecular immunology - 1 Feb 2018
Liu Shuxun, Yi Lin, Ling Ma, Jiang Jinxia, Song Lijun, Liu Juan, Cao Xuetao
Abstract excerpt
Heat-shock protein (HSP)-based immunotherapy is established on its adjuvant effects when applied via an extracellular approach to pulse and activate dendritic cells (DCs). Our previous studies indicate that DCs pulsed with recombinant fusion proteins of antigenic fragment and HSP70-like protein 1 (HSP70L1) are potent in stimulating antigen-specific Th1 responses. We herein evaluated the cytotoxic T cell (CTL)...
Topics
- Adenoviridae
- Animals
- Cancer Vaccines
- Cell Line, Tumor
- Cytokines
- Dendritic Cells
- HEK293 Cells
- HSP70 Heat-Shock Proteins
- Humans
- Inflammation Mediators
- MAP Kinase Signaling System
